Antimycobacterial activities of 5-alkyl (or halo)-3′-substituted pyrimidine nucleoside analogs

被引：14

作者：

Srivastav, Naveen C. ^{[1
]}

Shakya, Neeraj ^{[1
]}

Bhavanam, Sudha ^{[1
]}

Agrawal, Amogh ^{[1
]}

Tse, Chris ^{[1
]}

Desroches, Nancy ^{[1
]}

Kunimoto, Dennis Y. ^{[2
]}

Kumar, Rakesh ^{[1
]}

机构：

[1] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2H7, Canada

[2] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB T6G 2H7, Canada

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 02期

基金：

加拿大健康研究院;

关键词：

Tuberculosis; Pyrimidine nucleosides; MYCOBACTERIUM-TUBERCULOSIS; ANTIVIRAL ACTIVITY; RESISTANT; BOVIS; DEOXYRIBONUCLEOSIDES; 3'-AZIDO; STRAINS; HIV-1;

D O I：

10.1016/j.bmcl.2011.11.114

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Several 5-alkyl (or halo)-3'-azido (amino or halo) analogs of pyrimidine nucleosides have been synthesized and evaluated against Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium. Among these compounds, 3'-azido-5-ethyl-2',3'-dideoxyuridine (3) was found to have significant antimycobacterial activities against M. bovis (MIC50 = 1 mu g/mL), M. tuberculosis (MIC50 = 10 mu g/mL) and M. avium (MIC50 = 10 mu g/mL). (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：1091 / 1094

页数：4

共 28 条

[1] Addo Kk, 2007, Ghana Med J, V41, P52
[2] Aerschot A.V., 1990, J MED CHEM, V33, P1833
[3] [Anonymous], 2006, Lancet, V368, P964
[4] [Anonymous], WHOCDSTB2003
[5] [Anonymous], 2008, TUB INF LAT TUB INF
[6] STRUCTURE ACTIVITY RELATIONSHIPS OF PYRIMIDINE NUCLEOSIDES AS ANTIVIRAL AGENTS FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
CHU, CK
SCHINAZI, RF
AHN, MK
ULLAS, GV
GU, ZP
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) : 612 - 617
[7] Epidemiology of infection by nontuberculous mycobacteria
Falkinham, JO
[J]. CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) : 177 - +
[8] Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay
Franzblau, SG
Witzig, RS
McLaughlin, JC
Torres, P
Madico, G
Hernandez, A
Degnan, MT
Cook, MB
Quenzer, VK
Ferguson, RM
Gilman, RH
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) : 362 - 366
[9] An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
Griffith, David E.
Aksamit, Timothy
Brown-Elliott, Barbara A.
Catanzaro, Antonino
Daley, Charles
Gordin, Fred
Holland, Steven M.
Horsburgh, Robert
Huitt, Gwen
Iademarco, Michael F.
Iseman, Michael
Olivier, Kenneth
Ruoss, Stephen
von Reyn, C. Fordham
Wallace, Richard J., Jr.
Winthrop, Kevin
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) : 367 - 416
[10] Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection
Guerrero, A
Cobo, J
Fortun, J
Navas, E
Quereda, C
Asensio, A
Canon, J
Blazquez, J
GomezMampaso, E
[J]. LANCET, 1997, 350 (9093) : 1738 - 1742

← 1 2 3 →